| Entry |
|
|---|
| Name |
Bulevirtide (USAN/INN);
Hepcludex (TN) |
|---|
| Structure |
 |
|---|
| Sequence |
|
|---|
| Type |
Peptide |
|---|
| Remark |
|
|---|
| Efficacy |
Antiviral, Entry inhibitor |
|---|
| Type |
Modified peptide |
|---|
| Comment |
Treatment of chronic hepatitis delta virus infection and compensated liver disease
|
|---|
| Target |
HDV antigen |
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AX Other antivirals
J05AX28 Bulevirtide
D11877 Bulevirtide (USAN/INN)
Antimicrobials [BR:br08307]
Antivirals
Entry, fusion or uncoating inhibitor
Hepatitis virus antigen
D11877 Bulevirtide (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
